Wolverine Asset Management LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Wolverine Asset Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 13, 2021	SELL	$74.73 - $90.69 $52,311 - $63,483	-700 Reduced 77.78%	200 $15,000
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $56,352 - $63,432	-600 Reduced 40.0%	900 $87,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $114,015 - $148,545	1,500 New	1,500 $141,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.